Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil

Purpose: To compare treatment outcomes and adverse events between concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) and conventional concurrent chemoradiotherapy with cisplatin and 5-fluorouracil (CF-RT). Methods and Materials: We retrospectively investigated treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamaki, Yukihisa, Hieda, Yoko, Nakajima, Masanobu, Kitajima, Kazuhiro, Yoshida, Rika, Yoshizako, Takeshi, Ue, Atsushi, Tokudo, Mutsumi, Hirahara, Noriyuki, Moriyama, Ichiro, Kato, Hiroyuki, Inomata, Taisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096357/
https://www.ncbi.nlm.nih.gov/pubmed/30123343
http://dx.doi.org/10.7150/jca.23456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096357/
https://www.ncbi.nlm.nih.gov/pubmed/30123343
http://dx.doi.org/10.7150/jca.23456

Ejemplares similares